Last 12 months
Inside the activity.
0 purchase rows · 39 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 8 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 16, 2018 Filed Jul 17, 2018 22:08 UTC |
Rice MichaelDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,540 | $1.12 | $14,044.80 |
DisclosureSEC source: 0001437749-18-013390 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 09, 2018 Filed Jul 9, 2018 21:57 UTC |
VILLIGER WALTER10% owner
WAVI Holding AG10% owner
|
SaleCommon Stock | 24,857 | $11.37 | $282,624.09 |
DisclosureSEC source: 0001437749-18-013145 · rdgdoc.xml · nonDerivative · entry 2 VILLIGER WALTER · CIK 0001113655 · 10% owner WAVI Holding AG · CIK 0001603260 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By WAVI Holdings AG Disclosed balance after: 3,533,217 F1 · shares: The reporting person sold the shares in privately negotiated transactions. Read SEC document |
| July 09, 2018 Filed Jul 9, 2018 21:57 UTC |
VILLIGER WALTER10% owner
WAVI Holding AG10% owner
|
SaleCommon Stock | 189,429 | $11.37 | $2,153,807.73 |
DisclosureSEC source: 0001437749-18-013145 · rdgdoc.xml · nonDerivative · entry 1 VILLIGER WALTER · CIK 0001113655 · 10% owner WAVI Holding AG · CIK 0001603260 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By WAVI Holdings AG Disclosed balance after: 3,558,074 F1 · shares: The reporting person sold the shares in privately negotiated transactions. Read SEC document |
| July 09, 2018 Filed Jul 9, 2018 21:56 UTC |
GIRSCHWEILER THOMASDirector · 10% owner
Taurus4757 GmbHDirector · 10% owner
|
SaleCommon Stock | 252,571 | $11.37 | $2,871,732.27 |
DisclosureSEC source: 0001437749-18-013144 · rdgdoc.xml · nonDerivative · entry 2 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus Disclosed balance after: 1,513,963 F1 · shares: The reporting person sold the shares in privately negotiated transactions. Read SEC document |
| July 09, 2018 Filed Jul 9, 2018 21:56 UTC |
GIRSCHWEILER THOMASDirector · 10% owner
Taurus4757 GmbHDirector · 10% owner
|
SaleCommon Stock | 33,143 | $11.37 | $376,835.91 |
DisclosureSEC source: 0001437749-18-013144 · rdgdoc.xml · nonDerivative · entry 1 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus Disclosed balance after: 1,766,534 F1 · shares: The reporting person sold the shares in privately negotiated transactions. Read SEC document |
| June 18, 2018 Filed Jun 21, 2018 01:04 UTC |
Rice MichaelDirector · President & CEO
|
Exercise / conversionEmployee Stock Option · Derivative | 12,540 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001437749-18-012166 · rdgdoc.xml · derivative · entry 3 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,327 Underlying: Common Stock · 12,540 shares Expires 2021-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2018 Filed Jun 21, 2018 01:04 UTC |
Rice MichaelDirector · President & CEO
|
SaleCommon Stock | 12,540 | $12.89 | $161,640.60 |
DisclosureSEC source: 0001437749-18-012166 · rdgdoc.xml · nonDerivative · entry 2 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,517 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017, the terms of which have been disclosed in a Form 8-K filed by BioLife Solutions, Inc. on December 14, 2017. Read SEC document |
| June 18, 2018 Filed Jun 21, 2018 01:04 UTC |
Rice MichaelDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,540 | $1.12 | $14,044.80 |
DisclosureSEC source: 0001437749-18-012166 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 20:34 UTC |
Hinson Andrew GDirector
|
Exercise / conversionEmployee Stock Option · Derivative | 10,714 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001437749-18-011838 · rdgdoc.xml · derivative · entry 5 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,714 shares Expires 2020-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 20:34 UTC |
Hinson Andrew GDirector
|
Exercise / conversionEmployee Stock Option · Derivative | 10,714 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001437749-18-011838 · rdgdoc.xml · derivative · entry 4 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,714 shares Expires 2019-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 20:34 UTC |
Hinson Andrew GDirector
|
SaleCommon Stock | 10,000 | $11.25 | $112,500.00 |
DisclosureSEC source: 0001437749-18-011838 · rdgdoc.xml · nonDerivative · entry 3 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,474 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.10 to $11.40, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 20:34 UTC |
Hinson Andrew GDirector
|
Exercise / conversionCommon Stock | 10,714 | $1.40 | $15,010.31 |
DisclosureSEC source: 0001437749-18-011838 · rdgdoc.xml · nonDerivative · entry 2 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 20:34 UTC |
Hinson Andrew GDirector
|
Exercise / conversionCommon Stock | 10,714 | $1.26 | $13,510.35 |
DisclosureSEC source: 0001437749-18-011838 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2018 Filed Jun 6, 2018 00:07 UTC |
Schick Joseph CDirector
|
SaleCommon Stock | 6,858 | $10.07 | $69,058.69 |
DisclosureSEC source: 0001437749-18-011309 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,765 Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 21:58 UTC |
DE GREEF RODERICKChief Financial Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-18-011227 · rdgdoc.xml · derivative · entry 3 DE GREEF RODERICK · CIK 0001241181 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,919 Underlying: Common Stock · 10,000 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vests and becomes exercisable as follows: 85,960 shares vested on March 8, 2018 and 85,959 shares will vest on March 8, 2019. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 21:58 UTC |
DE GREEF RODERICKChief Financial Officer
|
SaleCommon Stock | 10,000 | $10.44 | $104,400.00 |
DisclosureSEC source: 0001437749-18-011227 · rdgdoc.xml · nonDerivative · entry 2 DE GREEF RODERICK · CIK 0001241181 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,583 Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 21:58 UTC |
DE GREEF RODERICKChief Financial Officer
|
Exercise / conversionCommon Stock | 10,000 | $1.64 | $16,400.00 |
DisclosureSEC source: 0001437749-18-011227 · rdgdoc.xml · nonDerivative · entry 1 DE GREEF RODERICK · CIK 0001241181 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 21:29 UTC |
COHEN RAYMOND WDirector
|
SaleCommon Stock | 10,000 | $10.15 | $101,500.00 |
DisclosureSEC source: 0001437749-18-011094 · rdgdoc.xml · nonDerivative · entry 1 COHEN RAYMOND W · CIK 0001258288 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,031 F1 · balance_after: Since the date of the reporting person's last ownership report, he transferred 2,625 shares of the registrant's common stock to his ex-wife pursuant to a domestic relations court order. The reporting person no longer reports as beneficially owned any securities owned by his ex-wife. Read SEC document |
| May 29, 2018 Filed May 29, 2018 22:30 UTC |
DE GREEF RODERICKChief Financial Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 15,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-18-010863 · rdgdoc.xml · derivative · entry 8 DE GREEF RODERICK · CIK 0001241181 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,919 Underlying: Common Stock · 15,000 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable as follows: 85,960 shares vested on March 8, 2018 and 85,959 shares will vest on March 8, 2019. Read SEC document |
| May 25, 2018 Filed May 29, 2018 22:30 UTC |
DE GREEF RODERICKChief Financial Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-18-010863 · rdgdoc.xml · derivative · entry 5 DE GREEF RODERICK · CIK 0001241181 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,919 Underlying: Common Stock · 10,000 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable as follows: 85,960 shares vested on March 8, 2018 and 85,959 shares will vest on March 8, 2019. Read SEC document |
| May 15, 2018 Filed May 16, 2018 23:54 UTC |
Rice MichaelDirector · President & CEO
|
Exercise / conversionEmployee Stock Options · Derivative | 12,540 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001437749-18-010178 · rdgdoc.xml · derivative · entry 3 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,867 Underlying: Common Stock · 12,540 shares Expires 2021-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2018 Filed May 16, 2018 23:54 UTC |
Rice MichaelDirector · President & CEO
|
SaleCommon Stock | 12,540 | $8.65 | $108,471.00 |
DisclosureSEC source: 0001437749-18-010178 · rdgdoc.xml · nonDerivative · entry 2 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,517 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017, the terms of which have been disclosed in a Form 8-K filed by BioLife Solutions, Inc. (the "Registrant") on December 14, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.56 to $8.7203, inclusive. The reporting person undertakes to provide to the Registrant, any security holder of the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 15, 2018 Filed May 16, 2018 23:54 UTC |
Rice MichaelDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,540 | $1.12 | $14,044.80 |
DisclosureSEC source: 0001437749-18-010178 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 20:22 UTC |
Rice MichaelDirector · President & CEO
|
Exercise / conversionEmployee Stock Option · Derivative | 5,900 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001437749-18-007095 · rdgdoc.xml · derivative · entry 6 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,407 Underlying: Common Stock · 5,900 shares Expires 2021-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 20:22 UTC |
Rice MichaelDirector · President & CEO
|
SaleCommon Stock | 5,900 | $7.22 | $42,598.00 |
DisclosureSEC source: 0001437749-18-007095 · rdgdoc.xml · nonDerivative · entry 4 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,517 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017, the terms of which have been disclosed in a Form 8-K filed by BioLife Solutions, Inc. (the "Registrant") on December 14, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.02 to $7.34, inclusive. The reporting person undertakes to provide to the Registrant, any security holder of the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 20:22 UTC |
Rice MichaelDirector · President & CEO
|
Exercise / conversionCommon Stock | 5,900 | $1.12 | $6,608.00 |
DisclosureSEC source: 0001437749-18-007095 · rdgdoc.xml · nonDerivative · entry 3 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 20:22 UTC |
Rice MichaelDirector · President & CEO
|
Exercise / conversionEmployee Stock Option · Derivative | 6,640 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001437749-18-007095 · rdgdoc.xml · derivative · entry 5 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,307 Underlying: Common Stock · 6,640 shares Expires 2021-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 20:22 UTC |
Rice MichaelDirector · President & CEO
|
SaleCommon Stock | 6,640 | $7.15 | $47,476.00 |
DisclosureSEC source: 0001437749-18-007095 · rdgdoc.xml · nonDerivative · entry 2 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,517 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017, the terms of which have been disclosed in a Form 8-K filed by BioLife Solutions, Inc. (the "Registrant") on December 14, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.05 to $7.30, inclusive. The reporting person undertakes to provide to the Registrant, any security holder of the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 20:22 UTC |
Rice MichaelDirector · President & CEO
|
Exercise / conversionCommon Stock | 6,640 | $1.12 | $7,436.80 |
DisclosureSEC source: 0001437749-18-007095 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 09, 2018 Filed Apr 10, 2018 23:26 UTC |
GIRSCHWEILER THOMASDirector · 10% owner
Taurus4757 GmbHDirector · 10% owner
|
SaleCommon Stock | 25,000 | $5.26 | $131,500.00 |
DisclosureSEC source: 0001437749-18-006639 · rdgdoc.xml · nonDerivative · entry 2 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus Disclosed balance after: 1,799,677 F1 · shares: The reporting person sold the shares in privately negotiated transactions. Read SEC document |
| April 09, 2018 Filed Apr 10, 2018 23:26 UTC |
GIRSCHWEILER THOMASDirector · 10% owner
Taurus4757 GmbHDirector · 10% owner
|
SaleCommon Stock | 1,000,000 | $5.26 | $5,260,000.00 |
DisclosureSEC source: 0001437749-18-006639 · rdgdoc.xml · nonDerivative · entry 1 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus Disclosed balance after: 1,824,677 F1 · shares: The reporting person sold the shares in privately negotiated transactions. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 20:30 UTC |
Rice MichaelDirector · President & CEO
|
Exercise / conversionEmployee Stock Option · Derivative | 12,540 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001144204-18-015309 · tv488755_4.xml · derivative · entry 3 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,947 Underlying: Common Stock · 12,540 shares Expires 2021-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The reporting person exercised this option to purchase 12,540 shares on February 15, 2018. For more information regarding that option exercise, see the Form 4 filed by the reporting person on February 16, 2018. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 20:30 UTC |
Rice MichaelDirector · President & CEO
|
SaleCommon Stock | 12,540 | $5.27 | $66,085.80 |
DisclosureSEC source: 0001144204-18-015309 · tv488755_4.xml · nonDerivative · entry 2 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,517 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017, the terms of which have been disclosed in a Form 8-K filed by BioLife Solutions, Inc. (the "Registrant") on December 14, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.28, inclusive. The reporting person undertakes to provide to the Registrant, any security holder of the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 20:30 UTC |
Rice MichaelDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,540 | $1.12 | $14,044.80 |
DisclosureSEC source: 0001144204-18-015309 · tv488755_4.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 22:03 UTC |
Foster Karen A.Vice President, Operations
|
GrantEmployee Stock Option · Derivative | 163,323 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001144204-18-013914 · tv488202_4.xml · derivative · entry 1 Foster Karen A. · CIK 0001683151 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,323 Underlying: Common Stock · 163,323 shares Expires 2021-12-20 F1 · derivative.exercise_date: As disclosed in the registrants annual report on Form 10-K for the year ended December 31, 2016, on December 20, 2016, the reporting person was granted an option to purchase 163,323 shares of common stock. The option vests in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 81,662 shares vested on March 8, 2018 and 81,661 shares will vest on March 8, 2019. No Form 4 filing was required upon the initial grant of the option because the option was subject to vesting based on conditions that were not tied to the passage of time and continued employment and not tied directly to the market price of the registrant's common stock. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 22:03 UTC |
Berard ToddVice President, Marketing
|
GrantEmployee Stock Option · Derivative | 123,209 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001144204-18-013913 · tv488201_4.xml · derivative · entry 1 Berard Todd · CIK 0001633186 · Vice President, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,209 Underlying: Common Stock · 123,209 shares Expires 2021-12-20 F1 · derivative.exercise_date: As disclosed in the registrants annual report on Form 10-K for the year ended December 31, 2016, on December 20, 2016, the reporting person was granted an option to purchase 123,209 shares of common stock. The option vests in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 61,605 shares vested on March 8, 2018 and 61,604 shares will vest on March 8, 2019. No Form 4 filing was required upon the initial grant of the option because the option was subject to vesting based on conditions that were not tied to the passage of time and continued employment and not tied directly to the market price of the registrant's common stock. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 22:02 UTC |
Mathers JamesVice President, Global Sales
|
GrantEmployee Stock Option · Derivative | 114,613 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001144204-18-013911 · tv488200_4.xml · derivative · entry 1 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,613 Underlying: Common Stock · 114,613 shares Expires 2021-12-20 F1 · derivative.exercise_date: As disclosed in the registrants annual report on Form 10-K for the year ended December 31, 2016, on December 20, 2016, the reporting person was granted an option to purchase 114,613 shares of common stock. The option vests in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 57,307 shares vested on March 8, 2018 and 57,306 shares will vest on March 8, 2019. No Form 4 filing was required upon the initial grant of the option because the option was subject to vesting based on conditions that were not tied to the passage of time and continued employment and not tied directly to the market price of the registrant's common stock. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 22:02 UTC |
Mathew Aby J.Sr. VP & Chief Tech. Officer
|
GrantEmployee Stock Option · Derivative | 197,707 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001144204-18-013910 · tv488199_4.xml · derivative · entry 1 Mathew Aby J. · CIK 0001556355 · Sr. VP & Chief Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,707 Underlying: Common Stock · 197,707 shares Expires 2021-12-20 F1 · derivative.exercise_date: As disclosed in the registrants annual report on Form 10-K for the year ended December 31, 2016, on December 20, 2016, the reporting person was granted an option to purchase 197,707 shares of common stock. The option vests in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 98,854 shares vested on March 8, 2018 and 98,853 shares will vest on March 8, 2019. No Form 4 filing was required upon the initial grant of the option because the option was subject to vesting based on conditions that were not tied to the passage of time and continued employment and not tied directly to the market price of the registrant's common stock. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 22:01 UTC |
DE GREEF RODERICKChief Financial Officer
|
GrantEmployee Stock Option · Derivative | 171,919 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001144204-18-013909 · tv488197_4.xml · derivative · entry 1 DE GREEF RODERICK · CIK 0001241181 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,919 Underlying: Common Stock · 171,919 shares Expires 2021-12-20 F1 · derivative.exercise_date: As disclosed in the registrants annual report on Form 10-K for the year ended December 31, 2016, on December 20, 2016, the reporting person was granted an option to purchase 171,919 shares of common stock. The option vests in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 85,960 shares vested on March 8, 2018 and 85,959 shares will vest on March 8, 2019. No Form 4 filing was required upon the initial grant of the option because the option was subject to vesting based on conditions that were not tied to the passage of time and continued employment and not tied directly to the market price of the registrant's common stock. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 22:00 UTC |
Rice MichaelDirector · President & CEO
|
GrantEmployee Stock Option · Derivative | 229,226 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001144204-18-013908 · tv488196_4.xml · derivative · entry 1 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,226 Underlying: Common Stock · 229,226 shares Expires 2021-12-20 F1 · derivative.exercise_date: As disclosed in the registrants annual report on Form 10-K for the year ended December 31, 2016, on December 20, 2016, the reporting person was granted an option to purchase 229,226 shares of common stock. The option vests in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 114,613 shares vested on March 8, 2018 and 114,613 shares will vest on March 8, 2019. No Form 4 filing was required upon the initial grant of the option because the option was subject to vesting based on conditions that were not tied to the passage of time and continued employment and not tied directly to the market price of the registrant's common stock. Read SEC document |
| February 15, 2018 Filed Feb 17, 2018 00:09 UTC |
Rice MichaelDirector · President & CEO
|
SaleCommon Stock | 12,540 | $5.26 | $65,960.40 |
DisclosureSEC source: 0001144204-18-009619 · tv486421_4.xml · nonDerivative · entry 2 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,517 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017, the terms of which have been disclosed in a Form 8-K filed by BioLife Solutions, Inc. (the "Registrant") on December 14, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.30, inclusive. The reporting person undertakes to provide to the Registrant, any security holder of the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 15, 2018 Filed Feb 17, 2018 00:09 UTC |
Rice MichaelDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,540 | $1.12 | $14,044.80 |
DisclosureSEC source: 0001144204-18-009619 · tv486421_4.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 23:04 UTC |
Mathew Aby J.Sr. VP & Chief Tech. Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,142 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001144204-18-002503 · tv483517_4.xml · derivative · entry 4 Mathew Aby J. · CIK 0001556355 · Sr. VP & Chief Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,142 shares Expires 2018-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments commencing on 11/05/2009 Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 23:04 UTC |
Mathew Aby J.Sr. VP & Chief Tech. Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,142 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001144204-18-002503 · tv483517_4.xml · derivative · entry 3 Mathew Aby J. · CIK 0001556355 · Sr. VP & Chief Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,142 shares Expires 2018-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable in four equal annual installments commencing on 02/11/2009 Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 23:04 UTC |
Mathew Aby J.Sr. VP & Chief Tech. Officer
|
Exercise / conversionCommon Stock | 7,142 | $0.56 | $4,006.66 |
DisclosureSEC source: 0001144204-18-002503 · tv483517_4.xml · nonDerivative · entry 2 Mathew Aby J. · CIK 0001556355 · Sr. VP & Chief Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 23:04 UTC |
Mathew Aby J.Sr. VP & Chief Tech. Officer
|
Exercise / conversionCommon Stock | 7,142 | $0.70 | $5,006.54 |
DisclosureSEC source: 0001144204-18-002503 · tv483517_4.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · Sr. VP & Chief Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 23:03 UTC |
Rice MichaelDirector · President & CEO
|
Exercise / conversionEmployee Stock Option · Derivative | 12,540 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001144204-18-002502 · tv483516_4.xml · derivative · entry 3 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,027 Underlying: Common Stock · 12,540 shares Expires 2021-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 23:03 UTC |
Rice MichaelDirector · President & CEO
|
SaleCommon Stock | 12,540 | $5.57 | $69,847.80 |
DisclosureSEC source: 0001144204-18-002502 · tv483516_4.xml · nonDerivative · entry 2 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,517 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017, the terms of which have been disclosed in a Form 8-K filed by BioLife Solutions, Inc. on December 14, 2017. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 23:03 UTC |
Rice MichaelDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,540 | $1.12 | $14,044.80 |
DisclosureSEC source: 0001144204-18-002502 · tv483516_4.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2018 Filed Jan 4, 2018 02:36 UTC |
COHEN RAYMOND WDirector
|
GrantCommon Stock | 3,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-18-000675 · tv482654_4.xml · nonDerivative · entry 2 COHEN RAYMOND W · CIK 0001258288 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,656 F3 · price: The shares of common stock were issued to the reporting person pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of receiving $18,750 of director fees for the quarter at a price per share based upon the closing stock price of the issuer's common stock on the last day of the quarter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.